Meningococcal Conjugate Vaccine in the United States: Remaining Challenges for Adolescent Vaccination

This publication has 14 references indexed in Scilit:

• National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017
  MMWR. Morbidity and Mortality Weekly Report, 2018
• Current Epidemiology and Trends in Meningococcal Disease—United States, 1996–2015
  Clinical Infectious Diseases, 2017
• Establishing an Immunization Platform for 16-Year-Olds in the United States
  Journal of Adolescent Health, 2017
• Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
  MMWR. Morbidity and Mortality Weekly Report, 2015
• Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
  2013
• Meningococcal disease: Clinical presentation and sequelae
  Vaccine, 2012
• Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010.
  2011
• Meningococcal carriage by age: a systematic review and meta-analysis
  The Lancet Infectious Diseases, 2010
• Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
  2005
• Standards for child and adolescent immunization practices. National Vaccine Advisory Committee.
  2003